Skip to main content
CMND logo

Clearmind Medicine Inc.

CMNDNASDAQHealthcareBiotechnology

$6.00Today:- (-)1Y −84.73%

As of Oct 22, 2026 close

Market cap
$1.19M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.05$48.00
Volume (live)
-
Avg. volume (3M)
28.82K

Clearmind Medicine (CMND) Stock Price & Financial Analysis

Clearmind Medicine Stock Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$6.00 - $6.00
52-Week High$48.00
52-Week Low$1.05
Open$6.00
Volume (last close)5.29K
Average Volume (3M)28.82K
Technical Indicators
50-Day MA$9.44
200-Day MA$7.59
1-Year Change−84.73%
Size & Valuation
Market Cap1.19M
Shares Outstanding197.77K
Price to Book (P/B)0.09
EV/EBITDA1.05
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%

Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology

Compare CMND with other stocks

Clearmind Medicine at a Glance

As of the Oct 22, 2026 close, Clearmind Medicine (CMND) has a market capitalization of $1.19M.

As of its latest reported balance sheet, it holds $12.04M in cash and securities against $1.72M of debt, a net cash position of $10.31M.

Clearmind Medicine does not currently pay a dividend.

The share price is down 84.7% over the past year. At $6.00 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $1.05 to $48.00, below its 200-day moving average of $7.59.

Frequently Asked Questions About Clearmind Medicine

What is the current stock price for CMND?

As of the Oct 22, 2026 close, CMND stock trades at $6.00. The 52-week range is $1.05–$48.00, with a day range of $6.00–$6.00.

What is the P/E ratio for CMND?

The P/E ratio (Price-to-Earnings) for CMND is shown in the Key Statistics section. This valuation metric helps compare Clearmind Medicine Inc. to industry peers.

Does CMND pay dividends?

Clearmind Medicine does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What do analysts recommend for CMND?

Analyst ratings and recommendations for CMND are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CMND?

As of the Oct 22, 2026 close, Clearmind Medicine's market capitalization is $1.2M, classifying it as a micro-cap company. Clearmind Medicine operates in the Healthcare sector within the Biotechnology industry.